Legal News

Seyfarth Synopsis: Following Delaware’s lead in Trulia, an Illinois District Court judge refused to approve a mootness fee settlement as “worthless to the shareholders.” The judge noted that such settlements amounted to a plaintiffs’ bar “racket”...By: Seyfarth Shaw LLP

Last week, Seyfarth submitted comments regarding the DOL’s proposal to update the federal regulations that set the standard for determining whether a business can be held liable as a joint employer under the FLSA....By: Seyfarth Shaw LLP

Seyfarth Synopsis: Earlier this week, Connecticut became the seventh state with a paid family leave program when Governor Ned Lamont signed the Paid Family and Medical Leave (“CPFML”) Act. CPFML premium withholdings begin on January 1, 2021 and...By: Seyfarth Shaw LLP

Seyfarth Synopsis: Since the enactment of New York City’s original Earned Sick Time Act (“ESTA”) in 2014, the City’s employers have dealt with a seemingly steady stream of updates expanding the law’s scope. In addition to the recent expansion...By: Seyfarth Shaw LLP

Seyfarth Synopsis: A new decision in the Southern District of New York held that the N.Y. prohibition of mandatory, pre-dispute arbitration of sexual harassment claims is preempted by the Federal Arbitration Act....By: Seyfarth Shaw LLP

Seyfarth Synopsis: Over the last few years, Illinois companies have quickly become aware of the risks associated with the state’s unique biometric privacy law. Originally passed in 2008, the Illinois Biometric Information Privacy Act (“BIPA”) made...By: Seyfarth Shaw LLP

Seyfarth Synopsis: Illinois Governor J.B. Pritzker signed the new recreational cannabis bill, which contains extensive provisions regarding the extent of an employer’s right to ban and otherwise discipline employees for cannabis use.  The legislation...By: Seyfarth Shaw LLP

Seyfarth Synopsis: The U.S. Supreme Court upheld this week a key component of administrative law that tells judges to defer to an executive agency’s interpretation of its own ambiguous regulation. Kisor v. Secretary of Veterans Affairs, No. 18-15...By: Seyfarth Shaw LLP

Seyfarth Synopsis: The federal Drug Enforcement Agency (DEA) recently announced that drugs that include CBD (cannabidiol) with less than 0.1% of THC (tetrahydrocannabinols) are now considered Schedule V drugs provided they are approved by the federal...By: Seyfarth Shaw LLP

Synopsis: ERISA stock-drop litigation has diminished in recent years due to the Supreme Court’s Dudenhoeffer decision (and a rising stock market). Now, the Court will have another chance to weigh in on whether federal ERISA litigation in this space...By: Seyfarth Shaw LLP